313 related articles for article (PubMed ID: 31670257)
1. Fabrication of biodegradable Mn-doped mesoporous silica nanoparticles for pH/redox dual response drug delivery.
Li X; Zhang X; Zhao Y; Sun L
J Inorg Biochem; 2020 Jan; 202():110887. PubMed ID: 31670257
[TBL] [Abstract][Full Text] [Related]
2. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
[TBL] [Abstract][Full Text] [Related]
3. pH and Ultrasound Dual-Responsive Polydopamine-Coated Mesoporous Silica Nanoparticles for Controlled Drug Delivery.
Li X; Xie C; Xia H; Wang Z
Langmuir; 2018 Aug; 34(34):9974-9981. PubMed ID: 30056720
[TBL] [Abstract][Full Text] [Related]
4. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.
Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G
Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764
[TBL] [Abstract][Full Text] [Related]
5. Polymer-Coated Hollow Mesoporous Silica Nanoparticles for Triple-Responsive Drug Delivery.
Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Luo Z; Zhao Y
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18179-87. PubMed ID: 26221866
[TBL] [Abstract][Full Text] [Related]
6. Fabrication of biodegradable auto-fluorescent organosilica nanoparticles with dendritic mesoporous structures for pH/redox-responsive drug release.
Li X; Chen Y; Zhang X; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110914. PubMed ID: 32409066
[TBL] [Abstract][Full Text] [Related]
7. pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.
Tian B; Liu S; Wu S; Lu W; Wang D; Jin L; Hu B; Li K; Wang Z; Quan Z
Colloids Surf B Biointerfaces; 2017 Jun; 154():287-296. PubMed ID: 28351801
[TBL] [Abstract][Full Text] [Related]
8. Gold-capped mesoporous silica nanoparticles as an excellent enzyme-responsive nanocarrier for controlled doxorubicin delivery.
Eskandari P; Bigdeli B; Porgham Daryasari M; Baharifar H; Bazri B; Shourian M; Amani A; Sadighi A; Goliaei B; Khoobi M; Saboury AA
J Drug Target; 2019 Dec; 27(10):1084-1093. PubMed ID: 30900473
[TBL] [Abstract][Full Text] [Related]
9. DPP-Cu
Chen W; Ma M; Lai Q; Zhang Y; Liu Z
Curr Med Chem; 2023; 30(28):3249-3260. PubMed ID: 36221869
[TBL] [Abstract][Full Text] [Related]
10. Dual-Therapeutics-Loaded Mesoporous Silica Nanoparticles Applied for Breast Tumor Therapy.
Li X; He G; Jin H; Tao J; Li X; Zhai C; Luo Y; Liu X
ACS Appl Mater Interfaces; 2019 Dec; 11(50):46497-46503. PubMed ID: 31738505
[TBL] [Abstract][Full Text] [Related]
11. Thermoresponsive polymer gated and superparamagnetic nanoparticle embedded hollow mesoporous silica nanoparticles as smart multifunctional nanocarrier for targeted and controlled delivery of doxorubicin.
Asghar K; Qasim M; Dharmapuri G; Das D
Nanotechnology; 2020 Nov; 31(45):455604. PubMed ID: 32311684
[TBL] [Abstract][Full Text] [Related]
12. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
13. Facile synthesis of organosilica-capped mesoporous silica nanocarriers with selective redox-triggered drug release properties for safe tumor chemotherapy.
Shen L; Pan S; Niu D; He J; Jia X; Hao J; Gu J; Zhao W; Li P; Li Y
Biomater Sci; 2019 Apr; 7(5):1825-1832. PubMed ID: 30892297
[TBL] [Abstract][Full Text] [Related]
14. Construction and Biological Evaluation of Multiple Modification Hollow Mesoporous Silicone Doxorubicin Nanodrug Delivery System.
Hu M; Zhang W; Chen W; Chen Y; Huang Q; Bao Q; Lin T; Wang L; Zhang S
AAPS PharmSciTech; 2022 Jun; 23(6):180. PubMed ID: 35761120
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent carbon dot modified mesoporous silica nanocarriers for redox-responsive controlled drug delivery and bioimaging.
Jiao J; Liu C; Li X; Liu J; Di D; Zhang Y; Zhao Q; Wang S
J Colloid Interface Sci; 2016 Dec; 483():343-352. PubMed ID: 27569517
[TBL] [Abstract][Full Text] [Related]
16. "Manganese Extraction" Strategy Enables Tumor-Sensitive Biodegradability and Theranostics of Nanoparticles.
Yu L; Chen Y; Wu M; Cai X; Yao H; Zhang L; Chen H; Shi J
J Am Chem Soc; 2016 Aug; 138(31):9881-94. PubMed ID: 27441571
[TBL] [Abstract][Full Text] [Related]
17. Magnetic targeting and pH-microwave dual responsive Janus mesoporous silica nanoparticles for drug encapsulation and delivery.
He Y; Wang C; Wu Q; Zhang G
Nanotechnology; 2024 May; 35(31):. PubMed ID: 38657569
[TBL] [Abstract][Full Text] [Related]
18. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
19. Multi-stimuli responsive mesoporous silica-coated carbon nanoparticles for chemo-photothermal therapy of tumor.
Lu H; Zhao Q; Wang X; Mao Y; Chen C; Gao Y; Sun C; Wang S
Colloids Surf B Biointerfaces; 2020 Jun; 190():110941. PubMed ID: 32169778
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
Zhang J; Sun Y; Tian B; Li K; Wang L; Liang Y; Han J
Colloids Surf B Biointerfaces; 2016 Aug; 144():293-302. PubMed ID: 27107383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]